OK-432 It isĀ the new intralesional injection used to treat lymphangioma. It is named OK-432 (picinabil). The following are the advantages of OK-432: Promising result It is an immuo-modulatory
OK-432 It isĀ the new intralesional injection used to treat lymphangioma. It is named OK-432 (picinabil). The following are the advantages of OK-432: Promising result It is an immuo-modulatory
If the lymphangioma is -small, cosmetically and functionally acceptable then observation and no treatment is required. Broomhead(1964) proposed 15% have spontaneous regression. Repeated aspiration To relieve from rapid growth
As a rule the diagnosis is apparent and are made on clinical grounds Ultrasound scanning may help To make prenatal diagnosis and there are report of infants being treated ex-utero